Protocol of controlled odorant stimulation for reducing apnoeic episodes in premature newborns: a randomised open-label Latin-square study with independent evaluation of the main endpoint (PREMODEUR)

INTRODUCTION: Apnoea affects 85% of premature infants under 34 weeks of age and would be an important risk factor for subsequent neuropsychological disorders. Currently, premature children with life-threatening apnoeas receive stimulants such as methylxanthines (mainly, caffeine) or doxapram (an ana...

Descripción completa

Detalles Bibliográficos
Autores principales: Duchamp-Viret, Patricia, Nguyen, Huu Kim, Maucort-Boulch, Delphine, Remontet, Laurent, Guyon, Aurore, Franco, Patricia, Cividjian, Andrei, Thevenet, Marc, Iwaz, Jean, Galletti, Sonia, Kassai, Behrouz, Cornaton, Elise, Plaisant, Franck, Claris, Olivier, Gauthier-Moulinier, Hélène
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Paediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438960/
https://www.ncbi.nlm.nih.gov/pubmed/34518252
http://dx.doi.org/10.1136/bmjopen-2020-047141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438960/
https://www.ncbi.nlm.nih.gov/pubmed/34518252
http://dx.doi.org/10.1136/bmjopen-2020-047141

Ejemplares similares